Valuation: Strides Pharma Science Limited

Market Cap 100B 1.03B 923M 859M 781M 1.47B 1.48B 10.34B 4.05B 51B 3.88B 3.8B 164B P/E 2027 *
15.9x
P/E 2028 * 11.4x
Enterprise Value 100B 1.03B 923M 859M 781M 1.47B 1.48B 10.34B 4.05B 51B 3.88B 3.8B 164B EV / Sales 2027 *
1.72x
EV / Sales 2028 * 1.45x
Free-Float
68.12%
Yield 2027 *
0.28%
Yield 2028 * 0.28%
1 day-1.09%
1 week+0.02%
Current month-3.10%
1 month-11.04%
3 months+0.13%
6 months+8.25%
Current year+20.04%
1 week 1,067.3
Extreme 1067.3
1,109.6
1 month 1,067.3
Extreme 1067.3
1,260.1
Current year 769.6
Extreme 769.6
1,260.1
1 year 769.6
Extreme 769.6
1,260.1
3 years 467.4
Extreme 467.4
1,675.25
5 years 263.45
Extreme 263.45
1,675.25
10 years 263.45
Extreme 263.45
1,675.25
Manager TitleAgeSince
Chief Executive Officer - 31/05/2024
Director of Finance/CFO 42 31/05/2024
Chief Tech/Sci/R&D Officer - 20/11/2024
Director TitleAgeSince
Chairman 65 -
Director/Board Member - 17/05/2017
Director/Board Member 82 17/05/2017
Change 5-day change 1-year change 3-year change Capi.($)
-1.09%+0.02% - - 1.03B
+0.83%+3.19%+41.49%+103.56% 1,051B
+1.93%+2.11%+37.08%+65.09% 630B
+1.49%+5.19%+19.94%+85.69% 489B
+2.26%+0.90%+69.32%+40.53% 359B
+1.45%+3.50%+23.29%+41.62% 344B
+1.17%+2.37%+13.47%+33.64% 272B
+0.89%+1.08%-6.13%+9.29% 246B
+1.82%+2.94%+42.99%+52.95% 224B
+2.77%+4.44%+29.01%+98.99% 187B
Average +1.35%+2.53%+30.05%+59.04% 422.63B
Weighted average by Cap. +1.47%+2.44%+33.36%+69.01%

Financials

2027 *2028 *
Net sales 58.23B 602M 537M 500M 455M 858M 862M 6.02B 2.36B 29.69B 2.26B 2.21B 95.27B 69.12B 714M 638M 593M 540M 1.02B 1.02B 7.14B 2.8B 35.24B 2.68B 2.62B 113B
Net income 6.28B 64.86M 57.93M 53.89M 49.02M 92.55M 92.95M 649M 254M 3.2B 244M 238M 10.27B 8.8B 90.91M 81.19M 75.53M 68.7M 130M 130M 909M 356M 4.49B 341M 334M 14.39B
Net Debt - -
Projected Income Statement - Annual - Strides Pharma Science Limited
Logo Strides Pharma Science Limited
Strides Pharma Science Limited is an India-based pharmaceutical company. The Company is focused on the development and manufacture of IP-led niche finished dosage formulations. The Company operates through two segments: Pharmaceutical and Bio-pharmaceutical. Its geographical segment includes Africa, Australia, Asia (excluding India), North America, Europe, India, and Others. The Company manufactures a range of niche and pharmaceutical products, including a range of dosage forms such as liquids, creams and ointments, soft gels, sachets, tablets, and modified release dosage formats. It has eight manufacturing units located in India (Bengaluru-two sites, Puducherry, and Chennai), Singapore, Italy (Milan), the United States (Florida) and Kenya (Nairobi). It is also engaged in manufacturing soft gelatin capsules. It develops and manufactures drugs in the anti-retroviral, anti-malarial, anti-tuberculosis, hepatitis, and other infectious disease drug segments for its institutional business.
Employees
3,535
Date Price Change Volume
09/10/26 ₹1,083.20 -1.09% 9,598
08/10/26 ₹1,095.15 -0.45% 9,435
07/10/26 ₹1,100.05 +1.13% 4,179
06/10/26 ₹1,087.75 +0.17% 11,069
05/10/26 ₹1,085.85 +0.27% 9,693
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Ratings Surperformance© - Strides Pharma Science Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1,085.30INR
Average target price
1,338.67INR
Spread / Average Target
+23.35%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Strides Pharma Science Limited